The Effect of Arista on Post-Operative Bleeding and Wound Drainage Following Mastectomy

NCT03647930 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-08-27

No results posted yet for this study

Summary

Study aim was to evaluate topical MPH on the risk of post-mastectomy seroma formation as measured by total drain output and total drain days.

Conditions

  • Seroma

Interventions

DEVICE

Microporous Polysaccharide Hemospheres (MPH)

Microporous Polysaccharide Hemospheres (MPH)

Sponsors & Collaborators

  • Memorial Health University Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-15
Primary Completion
2015-03-06
Completion
2015-03-06
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03647930 on ClinicalTrials.gov